Viewing Study NCT05518032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-05-18 @ 12:06 AM
Study NCT ID: NCT05518032
Status: WITHDRAWN
Last Update Posted: 2024-09-26
First Post: 2022-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)
Sponsor: Roswell Park Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Microsatellite Stable Colorectal Carcinoma View
None Recurrent Colorectal Carcinoma View
None Stage III Colorectal Cancer AJCC v8 View
None Stage IV Colorectal Cancer AJCC v8 View
None Unresectable Colorectal Carcinoma View
Keywords: